Aurealis Pharma AG

Aurealis Pharma is a Swiss-Finnish biopharmaceutical company with a technology platform facilitating combination therapy embedded in one single product that can be administered in a safe, efficient and cost-effective way. Safe food-grade lactic acid bacteria release multiple therapeutic human proteins locally in diseased tissue. Our first products are immuno-therapeutics to treat patients with chronic inflammatory wounds and cancer indications.

Aurealis Pharma AG
Technologiepark Basel
Hochbergerstrasse 60C
4057 Basel

Tel.: +41 79 944 15 80


company website

testimonial about Technologiepark Basel

Aurealis Pharma is delighted to have their office at the Technology Park Basel and appreciates the excellent support, infrastructure and opportunity to meet and exchange with other Life Science start-up and early stage companies.